Friday 16 March 2007: Symposium on Neuroendocrine Changes in Huntington´s Disease in Leiden, The Netherlands.
Organizers
EHDN and High-Q Foundation
Aims
- To arrange an opportunity for a broader group of
scientists and clinicians working with Huntington’s disease in Europe and that
are interested in hypothalamus and neuroendocrine factors, to meet and hear the
current research from world-leading experts.
- To stimulate new ideas on how to view HD and inspire
clinicians to investigate less studied aspects of HD such as sleep
disturbances, psychiatric symptoms, weight loss, changes in circadian rhythm
etc.
- To identify novel potential mediators of the pathogenesis
in HD, which will lead to new projects that would not have been initiated
otherwise.
Registration Registration is possible via email to Åsa Petersen and Marie-Noëlle Witjes-Ané. There is no fee. Participants (aside from the invited speakers) are kindly asked to cover their expenses for travel and accomodation out of their own pockets.
Information about the Symposium
LOCATION AND PROGRAM
Holiday Inn, Leiden, The Netherlands www.holiday-inn-leiden.com Haagse Schouwweg 10
2332 KG LEIDEN
+31 (0)71 53 55 555
Trains from Amsterdam-Schiphol Airport arrive to Leiden Central Railway
station 6 times per hour. A free shuttle service is available between
central station and the hotel in the early morning and late afternoon
from Monday to Friday.
Thursday 15 March: arrivals
20.00-22.00 Reception
Friday 16 March: symposium 8.30-9.00 Registration
9.00-9.15
Dr. Åsa Petersén and Prof. Bernhard Landwehrmeyer
Opening remarks
9.15-10.15
Prof. Dick Swaab, Dutch Institute for Neuroscience, Amsterdam, NL The human hypothalamus in health and disease
10.15-10.45Coffee
10.45-11.45
Ahmad Aziz, Leiden University Medical Center, NL
Hypothalamic changes in
Huntington’s disease
11.45-12.15
Dr. Marta Valenza, University of Milan, Italy
Dysfunction of the
cholesterol biosynthetic pathway in Huntington's disease and neurodegenerative
disorders
12.15-13.15
Lunch
13.15-14.15
Prof. Ruud M Buijs, Biomedicas Institute UNAM, Mexico city
Overview of
neuroendocrine regulation
14.15-14.45
Dr. Maria Björkqvist, Lund University, Sweden
Neuroendocrine factors as biomarkers for Huntington's disease
14.45-15.15 Coffee
15.15-15.45
Jorien van der Burg, Lund University, Sweden
Increased energy
metabolism in Huntington
disease mice
15.45-16.15
Dr. Patrick Weydt, Ulm University, Germany
PGC-1 alpha in the
metabolic dysregulation of Huntington's Disease 16.15-16.45
Dr. Sebastiaan Overeem, Leiden University Medical Center, NL
Narcolepsy and hypothalamic
pathology